S100A8 and S100A9 in human arterial wall. Implications for atherogenesis.
about
Identification of human S100A9 as a novel target for treatment of autoimmune disease via binding to quinoline-3-carboxamidesTarget-selective protein S-nitrosylation by sequence motif recognitionPro-inflammatory S100A8 and S100A9 proteins: self-assembly into multifunctional native and amyloid complexesMyeloid-related protein-8/14 is critical for the biological response to vascular injuryRole of NADPH oxidase in formation and function of multinucleated giant cellsMechanisms of ectopic calcification: implications for diabetic vasculopathyCytokines in the host response to Candida vaginitis: Identifying a role for non-classical immune mediators, S100 alarminsS100A8 and S100A9 in cardiovascular biology and diseaseDiabetic conditions promote binding of monocytes to vascular smooth muscle cells and their subsequent differentiationSynovial fluid proteomic fingerprint: S100A8, S100A9 and S100A12 proteins discriminate rheumatoid arthritis from other inflammatory joint diseases.Bacteria in the adventitia of cardiovascular disease patients with and without rheumatoid arthritisS-glutathionylation regulates inflammatory activities of S100A9.S100A12 mediates aortic wall remodeling and aortic aneurysm.ANTI-INFECTIVE PROTECTIVE PROPERTIES OF S100 CALGRANULINS.S100/Calgranulin-mediated inflammation accelerates left ventricular hypertrophy and aortic valve sclerosis in chronic kidney disease in a receptor for advanced glycation end products-dependent mannerProteomic analysis of circulating human monocytes in coronary artery disease.DAMPening inflammation by modulating TLR signalling.Microcalcifications in early intimal lesions of atherosclerotic human coronary arteriesSynthetic gestagens exert differential effects on arterial thrombosis and aortic gene expression in ovariectomized apolipoprotein E-deficient miceS100A12 suppresses pro-inflammatory, but not pro-thrombotic functions of serum amyloid A.Mechanisms of urokinase plasminogen activator (uPA)-mediated atherosclerosis: role of the uPA receptor and S100A8/A9 proteinsTLR9 ligands induce S100A8 in macrophages via a STAT3-dependent pathway which requires IL-10 and PGE2.Calprotectin (S100A8/S100A9) and myeloperoxidase: co-regulators of formation of reactive oxygen species.Calprotectin and platelet aggregation in patients with stable coronary artery diseaseS100/calgranulins EN-RAGEing the blood vessels: implications for inflammatory responses and atherosclerosisMatrix vesicles in the fibrous cap of atherosclerotic plaque: possible contribution to plaque rupture.Vesicular Location and Transport of S100A8 and S100A9 Proteins in Monocytoid Cells.Circulating S100A12 Levels Are Associated with Progression of Abdominal Aortic Calcification in Hemodialysis PatientsIn vivo targeting of inflammation-associated myeloid-related protein 8/14 via gadolinium immunonanoparticles.S100A12 in vascular smooth muscle accelerates vascular calcification in apolipoprotein E-null mice by activating an osteogenic gene regulatory programMyeloid-related protein 8 induces self-tolerance and cross-tolerance to bacterial infection via TLR4- and TLR2-mediated signal pathways.Role of Calprotectin as a Modulator of the IL27-Mediated Proinflammatory Effect on Endothelial Cells.Toll-like Receptors in the Vascular System: Sensing the Dangers Within.The Correlation of Serum Myeloid-Related Protein-8/14 and Eosinophil Cationic Protein in Patients with Coronary Artery DiseaseInterrelationship Between Periapical Lesion and Systemic Metabolic Disorders.Type 1 diabetes promotes disruption of advanced atherosclerotic lesions in LDL receptor-deficient mice.Review of S100A9 biology and its role in cancer.Macrophage-derived matrix vesicles: an alternative novel mechanism for microcalcification in atherosclerotic plaques.Functions of S100 proteins.Intriguing bronchoalveolar lavage proteome in a case of pulmonary langerhans cell histiocytosis.
P2860
Q21145828-853BA87A-DEE2-477E-B4AE-1377C4C258FBQ24307415-F8D18D19-9F0F-4023-BF29-3A9FAC5D8F58Q24312111-9C6A5AAA-F396-42AE-A959-63024191A8BCQ24627504-DEE0CD2D-6394-42F7-8CE6-3474F9AFF5ABQ24633426-3BB0B54C-EA71-4489-9226-F533145CB91FQ26778664-2EB8A41F-92C1-4830-9BD4-836932F90C86Q27021956-87986393-6CB0-45E4-BD10-878FE7733552Q27024450-F5A99E3A-DEA1-4A9B-BDE7-3279F1B60982Q30433016-73FA8875-2EBD-4C17-BE80-E8296119FEA0Q33526530-DA6F33B1-1A1F-4491-8F8B-047E4BE04007Q33686087-7D56BF1A-D586-4A62-BC52-A14605DCDF73Q33825064-70C1E1DF-7774-4EBF-9B25-D4FE6C656BEFQ33883852-5F5D08C5-D7CF-4FC1-B4D5-B207AD04199FQ33890061-B2C756BB-7CA6-4D97-B3E2-FDF8963157E9Q33939707-7A990229-7781-49CF-828B-98B2E351795BQ34027425-E826153A-1BB2-401B-BA95-F5287A95DD50Q34035570-3467DF67-2122-47D7-A308-1EA4462A516CQ34181316-B9A4779E-9562-46CF-9EC6-D0F6D8C5FFF5Q34619444-1DFF817F-FEDB-4525-9230-46CBBD5C7786Q34701317-B04A33BF-39FE-47BF-8FA1-6DB3DB179C36Q35063189-B44164BF-4170-470A-98E7-04FDB4700977Q35220162-A8996D9E-2054-4935-93DD-BFAE89D7BBDAQ35506742-4198AF85-B3F7-47AE-96A9-50E20BED2D3EQ35603084-C0004A0D-4AA8-4917-BC91-DC97D7BB39DBQ35627729-8C9593B5-49C6-4B8D-87E1-5AB648F39761Q35862512-182ACAF5-32E6-464C-A314-B58403555598Q35867672-3A117621-D1DF-4DA9-8DBF-EDA2521C349AQ35935760-37B54C9F-386C-439D-8358-5BCAB76145C4Q35947472-F4E02879-CBA7-46A1-BA06-1827A50C3C5AQ35998253-449D8726-27E4-434B-AEC2-39174407DC9DQ36273719-7E5DDBC7-5F17-4ACD-86C5-6F67570C9BF4Q36333169-E4D98FBA-0666-4425-9A29-CE663931364DQ36453194-FC2A40CA-0B9B-43C2-9A35-D2FE8C2058B2Q36679717-44F82B2C-23E2-40FC-9074-82AA5F2C6256Q36869664-879DBB3E-E73C-4A5D-9B4D-7AA587CE9677Q36883079-1712E232-A72D-4B18-A190-F4A44C3DBCD3Q36896567-8E976DFA-E153-4928-A30D-555B1F5187D8Q36990315-93C53080-8DA9-4D15-AB88-2E4AFFD14480Q37001259-02DEDD31-BEC5-427C-B946-00FBFDA7AF0FQ37024708-ABCAFB27-24A6-47E8-9B18-0AF0DA44ECAB
P2860
S100A8 and S100A9 in human arterial wall. Implications for atherogenesis.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
S100A8 and S100A9 in human arterial wall. Implications for atherogenesis.
@en
S100A8 and S100A9 in human arterial wall. Implications for atherogenesis.
@nl
type
label
S100A8 and S100A9 in human arterial wall. Implications for atherogenesis.
@en
S100A8 and S100A9 in human arterial wall. Implications for atherogenesis.
@nl
prefLabel
S100A8 and S100A9 in human arterial wall. Implications for atherogenesis.
@en
S100A8 and S100A9 in human arterial wall. Implications for atherogenesis.
@nl
P2093
P2860
P50
P356
P1476
S100A8 and S100A9 in human arterial wall. Implications for atherogenesis
@en
P2093
Carolyn L Geczy
Michelle M McCormick
Reginald S A Lord
Yuri V Bobryshev
P2860
P304
41521-41529
P356
10.1074/JBC.M509442200
P407
P577
2005-10-10T00:00:00Z